These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21733234)

  • 1. Evidence-based pharmacotherapy of panic disorder: an update.
    Batelaan NM; Van Balkom AJ; Stein DJ
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):403-15. PubMed ID: 21733234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based pharmacotherapy of panic disorder.
    Bakker A; van Balkom AJ; Stein DJ
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):473-82. PubMed ID: 15804373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication discontinuation in panic disorder.
    Ballenger JC
    J Clin Psychiatry; 1992 Mar; 53 Suppl():26-31. PubMed ID: 1548252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):27S-31S. PubMed ID: 9872710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder.
    Simon NM; Safren SA; Otto MW; Sharma SG; Lanka GD; Pollack MH
    J Affect Disord; 2002 May; 69(1-3):201-8. PubMed ID: 12103467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse prevention in panic disorder with pharmacotherapy: where are we now?
    Caldirola D; Alciati A; Daccò S; Micieli W; Perna G
    Expert Opin Pharmacother; 2020 Oct; 21(14):1699-1711. PubMed ID: 32543949
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term management of panic disorder.
    Doyle A; Pollack MH
    J Clin Psychiatry; 2004; 65 Suppl 5():24-8. PubMed ID: 15078115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of panic disorder: proposed guidelines for the family physician.
    Roy-Byrne P; Stein M; Bystrisky A; Katon W
    J Am Board Fam Pract; 1998; 11(4):282-90. PubMed ID: 9719350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants in panic disorder.
    Wade AG
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S13-7. PubMed ID: 10471168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of panic disorder.
    Shelton RC
    Hosp Community Psychiatry; 1993 Aug; 44(8):725-6. PubMed ID: 8104161
    [No Abstract]   [Full Text] [Related]  

  • 11. New treatment options for panic disorder: clinical trials from 2000 to 2010.
    Freire RC; Hallak JE; Crippa JA; Nardi AE
    Expert Opin Pharmacother; 2011 Jun; 12(9):1419-28. PubMed ID: 21342080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotherapy of panic disorder].
    Bougerol T; Farisse J
    Encephale; 1996 Dec; 22 Spec No 5():46-53. PubMed ID: 9138947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment options for panic disorder in children and adolescents.
    Masi G; Pari C; Millepiedi S
    Expert Opin Pharmacother; 2006 Apr; 7(5):545-54. PubMed ID: 16553570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments for panic disorder.
    Klerman GL
    J Clin Psychiatry; 1992 Mar; 53 Suppl():14-9. PubMed ID: 1532177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panic disorder. Pathophysiology and drug treatment.
    Johnson MR; Lydiard RB; Ballenger JC
    Drugs; 1995 Mar; 49(3):328-44. PubMed ID: 7774510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between concentrations of adinazolam and its primary metabolite in plasma and therapeutic/untoward effects in the treatment of panic disorder.
    Fleishaker JC; Greist JH; Jefferson JW; Sheridan AQ
    J Clin Psychopharmacol; 1994 Feb; 14(1):28-35. PubMed ID: 8151001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirically supported treatments for panic disorder.
    McHugh RK; Smits JA; Otto MW
    Psychiatr Clin North Am; 2009 Sep; 32(3):593-610. PubMed ID: 19716992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of GABAA receptors for the pathophysiology and therapy of panic disorders].
    Rupprecht R; Zwanzger P
    Nervenarzt; 2003 Jul; 74(7):543-51. PubMed ID: 12861364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panic disorder: clinical features, neurobiology, and pharmacotherapy.
    Breier A
    N Y State J Med; 1991 Nov; 91(11 Suppl):43S-47S. PubMed ID: 1771059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adinazolam sustained-release treatment of panic disorder: a double-blind study.
    Davidson JR; Beitman B; Greist JH; Maddock RJ; Lewis CP; Sheridan AQ; Carter C; Krishnan KR; Liebowitz MR; Haack DG
    J Clin Psychopharmacol; 1994 Aug; 14(4):255-63. PubMed ID: 7962681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.